Abstract SHARPIN (Shank-Associated RH Domain-Interacting Protein) is a component of the linear ubiquitin chain assembly complex (LUBAC), which enhances TNF-induced NF-κB activity. SHARPIN-deficient (Sharpin cpdm/cpdm ) mice display multi-organ inflammation and chronic proliferative dermatitis (cpdm) due to TNF-induced keratinocyte apoptosis. In cells, SHAR-PIN also inhibits integrins independently of LUBAC, but it has remained enigmatic whether elevated integrin activity levels in the dermis of Sharpin cpdm/cpdm mice is due to increased integrin activity or is secondary to inflammation. In addition, the functional contribution of increased integrin activation to the Sharpin cpdm/cpdm phenotype has not been investigated.
Introduction
Mice that lack the multifunctional adaptor protein SHARPIN (Sharpin cpdm/cpdm ) display progressive multi-organ inflammation, which most prominently manifests with chronic eosinophilic hyperproliferative dermatitis characterized by skin thickening, keratinocyte hyperproliferation and severe inflammation [1, 2] , which are characteristics of psoriasiform dermatitis. Importantly, these pathological features in the skin are cell autonomous, as Sharpin cpdm/cpdm grafts on wild type mice maintain the inflammatory phenotype [3] . As an important component of the Linear Ubiquitination Assembly Complex (LUBAC) [4] [5] [6] , SHARPIN regulates canonical a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 NF-κB (Nuclear factor-kappaB) signaling downstream of several receptors, such as Tumor Necrosis Factor receptor (TNFR) [7] , Toll-like receptor 2 [8] , Toll-like receptor 3 [9] , Interleukin1 receptor [4] [5] [6] and CD40 [5, 10] . The role of NF-κB in the skin epidermis is controversial as some studies point to a pivotal role for NF-κB signaling in restraining epidermal growth (for example [11] [12] [13] ), while other studies suggest that NF-κB signaling does not regulate development and differentiation of the epidermis (such as [14, 15] ) mice almost fully rescue the inflammatory and dermatitis phenotypes of Sharpin cpdm/cpdm mice [6, 16, 17] , although other phenotypes were not rescued, such as abnormal leukocyte cell count, the absence of Peyer's patches and absence of marginal zones in spleen [6, 16] . Mechanistically, an increase in TNF-induced keratinocyte apoptosis in the absence of LUBAC-mediated NF-kB signaling drives the systemic inflammation and hyperproliferative dermatitis in Sharpin cpdm/cpdm mice [6, 16, 17] .
Integrins are the major cell adhesion receptors that mediate the interaction of a cell with the surrounding extracellular matrix, including the basement membrane. Binding of integrins to extracellular ligands triggers a conformational change in integrin structure that allows recruitment of a plethora of cellular factors resulting in activation of several signaling pathways [18] . SHARPIN acts as an integrin inhibitor through binding to the integrin cytoplasmic domain, preventing the recruitment of integrin activating proteins and supporting the integrin inactive conformation [19] . Functionally, SHARPIN-mediated integrin inhibition regulates cell adhesion and migration [19] , as well as lymphocyte detachment during transmigration [20] . Importantly, SHARPIN plays mutually exclusive roles in regulating integrins and LUBAC such that SHARPIN inhibits integrins independent of LUBAC [21] .
Deregulated integrin activity is implicated in many human pathological conditions, including immune diseases, skin blistering, bleeding disorders, and cancer [18] . In the skin, integrin expression is predominantly confined to the basal keratinocytes that anchor the epidermis to the basal lamina [22, 23] . Transgenic mice overexpressing integrin beta 1 (Itgb1) in the suprabasal layer of the epidermis (Tg(Itgb1)0869Fmw) exhibit epidermal hyperproliferation, perturbed keratinocyte differentiation and skin inflammation [24] , which resembles the Sharpin cpdm/cpdm phenotype. Furthermore, integrin blocking therapies have been shown to alleviate psoriasis in mice [25] and in human patients [26] . These data suggest that increased integrin activation in Sharpin cpdm/cpdm mice may contribute to the dermatitis phenotype. We have previously demonstrated increased Itgb1 activity in the basal layer of the epidermis of Sharpin cpdm/cpdm mice [19] . However, whether this was due to the absence of SHARPIN-mediated integrin inhibition or secondary to the chronic inflammation-driven proliferative dermatitis has remained unclear. 
Results
Itgb1 activation is elevated in basal keratinocytes from Tnfr1-/-Sharpincpdm/cpdm mice with normal epidermal thickness
We previously showed increased levels of active Itgb1 in the basal layer of the epidermis of Sharpin cpdm/cpdm mouse skin [19] , consistent with SHARPIN-mediated integrin inhibition. , but not in control mice (Fig 2A-2C ), without significantly affecting dermal thickness (Panel C in S1 Fig) . From each animal the epidermal thickness was measured from five individual tissue sections with two measurements per skin section, thus minimizing the chances of recording experimental outliers. Importantly, plotting all data showed equal Staining for the proliferation marker Ki67 indicated that inhibition of Itgb1 in Sharpin cpdm/cpdm mice reduced the number of proliferating epidermal cells (Fig 2D and 2E) showing that the Itgb1 blocking antibody inhibits keratinocyte proliferation autonomously and suggesting that amelioration of the chronic proliferative dermatitis (Fig 2A-2C ) is, at least partly, linked to decreased keratinocyte proliferation. (Fig 4A and 4B) . Since Tnf levels remained high despite Itgb1 antibody treatment (Panel B and C in S2 Fig) , the reduction in apoptotic cell numbers could rather be related to the decreased proliferation as keratinocyte apoptosis balances cell proliferation to control epidermal thickness [32] . These data suggest that inhibition of integrin activity in Sharpin cpdm/cpdm mice with an anti-Itgb1 antibody ameliorates the chain reaction leading to hyperproliferative dermatitis in the absence of SHARPIN. 
Itgb1 inhibition does not reduce the chronic inflammation in

Discussion
The multifunctional adaptor protein SHARPIN regulates integrins [19, 20] and TNF-induced NF-kB signaling [4] [5] [6] , but whether defective integrin regulation also contributes to the Sharpin cpdm/cpdm skin phenotype has remained unknown [33] . This study now demonstrates that Itgb1 inhibition in Sharpin cpdm/cpdm mice significantly reduces epidermal proliferation and apoptosis, suggesting a modulatory role for integrins in the chronic proliferative dermatitis phenotype. Through direct interaction with the integrin cytoplasmic domain SHARPIN inhibits integrin activity, which plays a role in cell adhesion and migration [19, 20] . Consistently, increased levels of active Itgb1 were observed in the epidermis of Sharpin cpdm/cpdm mice [19] . However, [6, 16, 17] .
Transgenic mice with suprabasal expression of Itgb1 displayed similar chronic proliferative dermatitis with deregulated keratinocyte proliferation and skin inflammation, although apoptosis was not significantly affected [24] . In Sharpin cpdm/cpdm mice, however, the increased Itgb1 activity was primarily observed in basal keratinocytes negative for Keratin-10 or involucrin expression [19] . 
Materials and methods
Mice
The C57BL/KaLawRij-Sharpin cpdm /RijSunJ mouse strain (Stock No: 007599 |) with a spontaneous mutation leading to the complete loss of SHARPIN protein [1, 2] was acquired from The Jackson Laboratory (Bar Harbor, ME). The colony was maintained in heterozygote breeding and genotyped for the ), obtained from Prof. H. Walczak, were also maintained in heterozygote breeding. PCR amplification was used for detection of the deletion in Tnfr1 gene in somatic DNA. Age-matched mice were used in all the experiments described here. As both male and female Sharpin cpdm/cdpm mice develop the same symptoms and we have to perform heterozygous breedings, both genders were used in the experiments. Mice were housed in standard conditions (12-h light/dark cycle) with food and water available ad libitum. The viability, clinical signs and behaviour of the mice were monitored daily. 
Antibody treatment of mice
Five pairs of 5-week old gender-matched Sharpin cpdm/cpdm and Sharpin +/? littermates were injected intraperitoneally with 0.1 ml of 0.05 mg/ml function-blocking anti-mouse ITGB1 antibody (LEAF™ purified anti-mouse CD29 Armenian hamster IgG (clone HMB1-1, Biolegend) or PBS twice a week. Mice were injected for a total of 3 weeks (6 injections) and then euthanized by CO 2 asphyxiation. Complete necropsies were performed as described [36] . Skin was collected in Fekete's acid-alcohol-formalin. Dorsal skin was also collected in 4% paraformaldehyde for immunofluorescence or fresh frozen for IHC. Blood was collected in EDTA tubes for analysis using the ADVIA 120 Hematology System (Siemens Healthcare Global). Four pairs of 5-week old littermates injected with 0.1 ml of 0.5 mg/ml anti-mouse CD29 antibody or Armenian hamster IgG negative control antibody (Biolegend) showed highly similar results.
Antibodies
The Immunofluorescence O.C.T. (Sakura) embedded frozen skin sections were fixed (4% paraformaldehyde), quenched (100mM glycine in PBS), and blocked/permeabilized (2% BSA, 0.1% Triton X100 in PBS). Samples were labeled with primary antibodies (1 hour at RT in 2% BSA in PBS), washed three times and labeled with fluorescent secondary antibodies. After washes, samples were mounted in Vectashield mounting medium (Vector Laboratories) and viewed using a 20x objective on either a 3i Marianas Spinning disk confocal microscope (Intelligent Imaging Innovations) or Zeiss Axiovert 200M with Yokogawa CSU22 spinning disk confocal microscope unit with Hamamatsu Orca ER CCD camera (Hamamatsu Photonics K.K.). Images were processed and quantified using Fiji image analysis software [37] .
Isolation and culture of mouse primary keratinocytes 6-8 weeks old littermate mice were sacrificed, dorsal skin was shaved and a piece of dorsal skin (1.5 cm x 1.5 cm) was harvested in cold PBS. Tissue was cut further to smaller pieces, rinsed with Hank's Balanced Salt Solution without Ca 2+ and Mg 2+ (HBSS; Sigma), and incubated overnight in 0,25% porcine trypsin (Sigma) in HBSS at +4˚C on a shaker. Next day, the dermis was removed with forceps, the remaining epidermis was chopped with a scalpel and incubated in 0.2% Collagenase XI (Sigma) at 37˚C incubator for 30 min. Keratinocytes were dissociated from the tissue by pipetting the suspension every 5-10 minutes. Keratinocytes were filtered through a cell strainer (70 μm; BD Biosciences). Finally, cells were incubated with 20 U/ml DNase I (Roche) for 5 min on ice and spun down. Primary keratinocytes were cultured on a 6-well plate coated with 20 μg/ml Collagen Type I from rat tail (Merck Millipore) in FAD medium [Dulbecco's Modified Eagle's Medium:Ham's F12 Nutrient Mixture (GIBCO) 3.5:1.1] supplemented with 10% fetal bovine serum (FBS) (chelated using Bio-Rad Chelex 1 100 Chelating Resin), 5 μg/ml insulin, 100 pM choleratoxin, 10 ng/ml epidermal growth factor (EGF), 100 U/ml sodium pyruvate, 100 μg/ml penicillinstreptomycin and 0.5 μg/ml hydrocortisone (all from Sigma Aldrich if not otherwise mentioned) in 5% CO 2 and 32˚C.
Keratinocyte proliferation assay
Equal amounts of primary mouse keratinocytes were plated on 96-well plates coated with 20 μg/ml rat tail Collagen Type I. One day after seeding, the keratinocytes were treated with 10 μg/ml anti-Itgb1(Anti-mouse CD29 Armenian hamster IgG) or isotype IgG control antibody. Theamount of cells) in each well was quantified with Cell Proliferation Reagent WST-1 (Roche, Sigma Aldrich) according to the manufacturer's instructions and a BioTek Synergy H1 Hybrid Multi-Mode Microplate Reader. The relative proliferation was calculated by normalizing the amount of cells in each time point to day zero (Fig 2G) or by subtracting the amount of cells at day zero from the value at day two (corrected cell amount), followed by normalizing to the corrected cell amount of IgG control. A minimum of two wells per keratinocyte primary cell line were analysed per time point.
Flow cytometry
The active conformation specific Itgb1 antibody (clone 9EG7, BD Pharmingen) was concentrated with an Amicon 1 Ultra filter centrifugation and directly conjugated to Alexa Fluor 647
with APEX 1 antibody labelling kit (Thermo Fischer Scientific). Cells were fixed with 2% paraformaldehyde in PBS for 10 min at RT, after which they were centrifuged and washed with cold Tyrodes buffer (10 mM Hepes-NaOH pH 7. 
Western blotting
Protein content in primary mouse keratinocytes was analysed by immunoblotting using standard western blotting techniques and the Odyssey LICOR imaging system.
Statistical analysis
All statistical analyses were performed using GraphPad Prism (GraphPad Software, San Diego, USA). Normal distribution was assumed for the data and unpaired Student's t-test was used for all experiments. A p < 0.05 was considered significant. Supervision: Emilia Peuhu, John P. Sundberg, Jeroen Pouwels.
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